{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:14:17Z","timestamp":1784258057662,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Parathyroid carcinoma (PC) is a very rare endocrine malignancy occurring in less than 1% of all cases of primary hyperparathyroidism (pHPT). The liver is the second most common target organ for distant metastases of PC, but no guidelines are available for the diagnosis and treatment of liver metastases. In this study, we attempted to summarize the characteristics of the diagnosis and treatment of liver metastases based on our patients and other cases reported in the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The files of all patients diagnosed with PC with liver metastases summarized at our center between 2000 and 2022 were reviewed, and three datasets from Medline, Web of Science, and Embase were systematically searched to identify relevant articles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Three patients with liver metastases from our center and 11 patients from the literature were included in the study. All patients had pHPT with borderline remission of hypercalcemia after each operation. A total of 71.4% of the patients\u2019 liver lesions were found by abdominal CT scans, while 35.7% were found by MRI, PET-CT, and fine-needle aspiration biopsy (FNAB), which were also helpful for diagnosis. Eight of nine patients (88.9%) who underwent surgery, radiofrequency ablation (RFA), or transcatheter arterial embolization (TAE) were alive, and only one postoperative patient died after a follow-up of 60 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PC is a rare malignant tumor prone to recurrence and metastasis, and postoperative reviews should be carried out routinely. Abnormally elevated parathyroid hormone (PTH) and serum calcium can indicate recurrence or metastasis. Enhanced CT and MRI can provide valuable support for the diagnosis of liver metastases, but whether [18F]FDG-PET-CT, [18F]FCH-PET-CT, or [11C]choline-PET-CT can be used as a diagnostic basis requires further study. Resection of liver metastases, segmental hepatectomy, or RFA can significantly improve patients\u2019 symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.982972","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T05:10:57Z","timestamp":1665465057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Diagnosis and treatment of liver metastases of parathyroid carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Chaoyun","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4901-9","article-title":"The incidence and survival of rare cancers of the thyroid, parathyroid, adrenal, and pancreas","volume":"23","author":"James","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: Parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07451-3","article-title":"Risk of distant metastasis in parathyroid carcinoma and its effect on survival: A retrospective review from a high-volume center","volume":"26","author":"Asare","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid cancer: A review","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.03.019","article-title":"The changing pattern of diagnosing primary hyperparathyroidism in young patients","volume":"213","author":"Lou","year":"2017","journal-title":"Am J Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8883413","DOI":"10.1155\/2020\/8883413","article-title":"Hypercalcemia of malignancy revealing a parathyroid carcinoma with hepatic metastasis: A case report and literature review","volume":"2020","author":"Mellagui","year":"2020","journal-title":"Case Rep Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.15446\/revfacmed.v65n3.55522","article-title":"Hepatic metastasis of a parathyroid carcinoma treated with intra-arterial embolization","volume":"65","author":"Gonz\u00e1lez-Clavijo","year":"2017","journal-title":"Rev la Facultad Medicina"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K09E-283","article-title":"First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma","volume":"57","author":"Horie","year":"2010","journal-title":"Endocr J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.9038","article-title":"Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization","volume":"26","author":"Artinyan","year":"2008","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-006-1173-6","article-title":"Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection","volume":"14","author":"Mezhir","year":"2007","journal-title":"J Hepato-Biliary-Pancreatic Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0189","article-title":"A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy","volume":"2","author":"Szmuilowicz","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.12.006","article-title":"Laparoscopic microwave tissue ablation of hepatic metastasis from a parathyroid carcinoma","volume":"31","author":"Ahmad","year":"2005","journal-title":"Ejso"},{"key":"B14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/oxfordjournals.jjco.a023192","article-title":"Successful resection of hepatic and pulmonary metastases in a patient with parathyroid carcinoma","volume":"26","author":"van Haaren","year":"1996","journal-title":"Japanese J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.142.3.7063676","article-title":"Radiographic findings in recurrent parathyroid carcinoma","volume":"142","author":"Krudy","year":"1982","journal-title":"Radiology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","article-title":"Parathyroid carcinoma - study of 70 cases","volume":"31","author":"Schantz","year":"1973","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-001-0028-2","article-title":"Parathyroid carcinoma","volume":"2","author":"Kebebew","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081018","article-title":"Parathyroid carcinoma","volume":"23","author":"Marcocci","year":"2008","journal-title":"J Bone Miner Res"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.47102\/annals-acadmedsg.V34N7p443","article-title":"Parathyroid carcinoma: A case series","volume":"34","author":"Cheah","year":"2005","journal-title":"Ann Acad Med Singap"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.48.213","article-title":"Ultrasonographic features of parathyroid carcinoma","volume":"48","author":"Hara","year":"2001","journal-title":"Endocr J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: A 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.clon.2010.04.007","article-title":"Parathyroid carcinoma","volume":"22","author":"Givi","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: A 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20152","article-title":"Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases","volume":"88","author":"Iacobone","year":"2004","journal-title":"J Surg Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2014","article-title":"Unusual case of solitary functioning bone metastasis from a \"parathyroid adenoma\": Imagiologic diagnosis and treatment with percutaneous vertebroplasty\u2013case report and literature review","volume":"98","author":"Qiu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.23736\/S1824-4785.22.03427-6","article-title":"An essential practice summary of the new EANM guidelines for parathyroid imaging","volume":"66","author":"Petranovic Ovcaricek","year":"2022","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v2.i10.348","article-title":"FDG-PET\/CT and parathyroid carcinoma: Review of literature and illustrative case series","volume":"2","author":"Evangelista","year":"2011","journal-title":"World J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.29.3.383","article-title":"Distant subcutaneous recurrence of a parathyroid carcinoma: Abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET\/CT imaging","volume":"29","author":"Kim","year":"2014","journal-title":"Korean J Intern Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.643328","article-title":"Case report: Abdominal lymph node metastases of parathyroid carcinoma: Diagnostic workup, molecular diagnosis, and clinical management","volume":"12","author":"Lenschow","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02487-y","article-title":"Will (18)F-fluorocholine PET\/CT replace other methods of preoperative parathyroid imaging","volume":"71","author":"Giovanella","year":"2021","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5190-4","article-title":"Benefit of (18)F-fluorocholine PET imaging in parathyroid surgery","volume":"28","author":"Huber","year":"2018","journal-title":"Eur Radiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14688","article-title":"Preoperative imaging in primary hyperparathyroidism: Are (11) c-choline PET\/CT and (99m) Tc-MIBI\/(123) iodide subtraction SPECT\/CT interchangeable or do they supplement each other","volume":"97","author":"Christensen","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13550-021-00778-7","article-title":"A retrospective analysis of the diagnostic performance of (11)C-choline PET\/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism","volume":"11","author":"Noltes","year":"2021","journal-title":"EJNMMI Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000607","article-title":"Localization of parathyroid adenoma by (1)(1)C-choline PET\/CT: Preliminary results","volume":"39","author":"Orevi","year":"2014","journal-title":"Clin Nucl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-006-0095-8","article-title":"Implantation of parathyroid carcinoma along fine needle aspiration track","volume":"391","author":"Agarwal","year":"2006","journal-title":"Langenbecks Arch Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0797-0","article-title":"Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism","volume":"35","author":"Takeuchi","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0166","article-title":"Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab","volume":"171","author":"Karuppiah","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3031","article-title":"Denosumab for management of parathyroid carcinoma-mediated hypercalcemia","volume":"99","author":"Vellanki","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.136.8.878","article-title":"Localization and reoperation results for persistent and recurrent parathyroid carcinoma","volume":"136","author":"Kebebew","year":"2001","journal-title":"Arch Surg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management","volume":"13","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hed.22908","article-title":"Parathyroid cancer: outcome analysis of 16 patients treated at the princess Margaret hospital","volume":"35","author":"Erovic","year":"2013","journal-title":"Head Neck"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-010-0042-6","article-title":"Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature","volume":"1","author":"Witteveen","year":"2010","journal-title":"Horm Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-009-9730-4","article-title":"A case report of 20 lung radiofrequency ablation sessions for 50 lung metastases from parathyroid carcinoma causing hyperparathyroidism","volume":"33","author":"Tochio","year":"2010","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.982972\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T14:53:24Z","timestamp":1728140004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.982972\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":44,"alternative-id":["10.3389\/fendo.2022.982972"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.982972","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"article-number":"982972"}}